MDM2 and neoplasm: As expected, key transcriptional targets of p53 (e.g., p21, PUMA, and Mdm2) were activated upon ML364 treatment of tumor lines expressing wild-type p53 (H460 and A375) but not in p53-null H1299 cells (Fig. 6a, b).